Panobacumab (KBPA101) is a fully humanised monoclonal antibody targeting Pseudomonas aeruginosa, specifically targeting the O-polysaccharide (OPS) component of the bacterial outer membrane LPS. It is effective against certain drug-resistant strains of P. aeruginosa, reduces pulmonary inflammation, and enhances the clearance of bacteria from the lungs by neutrophils.
Purity:
98.60%
CAS Number:
[885053-97-4]
Target:
Antibacterial
* VAT and and shipping costs not included. Errors and price changes excepted